Congressional Bills
H.R. 3 (Introduced in House)
26 sections
- PreambleTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and estab...
- Sec. 1Short title; table of contents
- Sec. 101Providing for lower prices for certain high-priced single source drugs
- Sec. 102Selected drug manufacturer excise tax imposed during noncompliance periods
- Sec. 103Fair Price Negotiation Implementation Fund
- Sec. 201Medicare part B rebate by manufacturers
- Sec. 202Medicare part D rebate by manufacturers
- Sec. 203Provision regarding inflation rebates for group health plans and group health insurance coverage
- Sec. 204Annual report on drug costs in group health plans and group health insurance coverage
- Sec. 205Collection of data
- Sec. 301Medicare part D benefit redesign
- Sec. 302Allowing certain enrollees of prescription drug plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances
- Sec. 303Establishment of pharmacy quality measures under Medicare part D
- Sec. 401Drug price transparency
- Sec. 501NIH Innovation Initiatives
- Sec. 502NIH clinical trial
- Sec. 503Innovation Network
- Sec. 511Food and Drug Administration
- Sec. 512Study on high-risk, high-reward drugs
- Sec. 521Overdose Epidemic Response Fund
- Sec. 522Substance Abuse and Mental Health Services Administration
- Sec. 523Centers for Disease Control and Prevention
- Sec. 524Food and Drug Administration
- Sec. 525National Institutes of Health
- Sec. 526Health Resources and Services Administration
- Sec. 527Administration for Children and Families